PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trialConnie Celum, Sinéad Delany‐Moretlwe, Sybil Hosek et al.|PLoS Medicine|2021Cited by 181
A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy studyWilliam C. Miller, David Burns, David S. Metzger et al.|The Lancet|2018Cited by 97
Expanding Substance Use Treatment Options for HIV Prevention With Buprenorphine–NaloxoneDavid S. Metzger, David Burns, Deborah Donnell et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2015Cited by 34
Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trialKostyantyn Dumchev, Irving Hoffman, Xu Guo et al.|BMC Infectious Diseases|2023Cited by 4